We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Cardiovascular Disease and Diabetes Increase Together

By HospiMedica staff writers
Posted on 30 Apr 2007
A new study shows that as rates of diabetes have risen in the United States, the proportion of cardiovascular disease (CVD) linked to diabetes mellitus (DM) has also increased.

Researchers from the of the U.S. More...
National Heart, Lung, and Blood Institute (NHLBI; Bethesda, MD, USA) compared risk factors for cardiovascular disease and cardiovascular events such as heart attacks in participants of the Framingham Heart Study from two different time periods. The first group was examined between 1952 and 1974, and the more recent group was examined between 1975 and 1998. A total of 9,540 individuals age 45 to 64 were evaluated. The age- and sex-adjusted hazard ratio for DM as a CVD risk factor was 3.0 in the earlier time period and 2.5 in the later time period; the population-attributable risk for DM as a CVD risk factor increased from 5.4% in the earlier time period to 8.7% in the later time period. Most of the increased risk was observed among men. The researchers also reported that the prevalence of diabetes among those with CVD almost doubled between the earlier and later time periods, and there was also an increase in the prevalence of obesity. The study was published in the March 27, 2007, issue of the journal Circulation.

"These findings emphasize the need for increased efforts to prevent diabetes and to aggressively treat and control CVD risk factors among those with diabetes,” said lead author Caroline Fox, M.D.

The Framingham Heart Study is a cardiovascular study based in Framingham (MA, USA). The study began in 1948 with 5,209 adult subjects from Framingham, and is on its third generation of participants at present. Most of the now common knowledge concerning heart disease, such as the effects of diet, exercise, and common medications such as aspirin, are based on this longitudinal study. It is a project of the NHLBI, in collaboration with (since 1971) Boston University (MA, USA).


Related Links:
U.S. National Heart, Lung, and Blood Institute
Boston University

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.